Share Name Share Symbol Market Type Share ISIN Share Description
AstraZeneca LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -7.50p -0.16% 4,680.50p 4,680.00p 4,680.50p 4,708.00p 4,666.50p 4,666.50p 1,018,603.00 16:23:36
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 18,627.4 2,876.5 224.3 21.6 59,207.57

AstraZeneca Share Discussion Threads

Showing 10276 to 10297 of 10300 messages
Chat Pages: 412  411  410  409  408  407  406  405  404  403  402  401  Older
DateSubjectAuthorDiscuss
25/4/2017
13:46
Good RNS today :-)
philanderer
21/4/2017
12:53
It's not making for a pleasant chart for April.
f1araway
21/4/2017
09:56
21st april Jefferies hold tp 4900p cut from 5050p
philanderer
19/4/2017
09:05
19th april Credit Suisse underperform tp 4000p reiterates
philanderer
18/4/2017
20:48
Rotation out of the dollar earners, pound very strong.
montyhedge
10/4/2017
12:48
Took a bit off battering this last couple off weeks
stevenrevell
10/4/2017
08:49
Or....Barclays 'overweight' target 6000p. ...reiterates
philanderer
10/4/2017
07:44
And downgraded by Jefferies today to 'hold' ...target cut from 5350p to 5050p
philanderer
07/4/2017
18:45
HSBC downgrade to reduce. Tp unch. 4500p
philanderer
05/4/2017
12:09
AstraZeneca, down 1.2%. The Anglo-Swedish drugmaker was cut to Neutral from Buy by UBS. Target 5150p up from 5000p
philanderer
03/4/2017
20:08
Keep a close eye on AstraZeneca (AZN). Potential reaction to U.S. FDA's perspective over its lung cancer drug Tagrisso http://crweworld.com/article/markets/66668/fda-hands-over-full-approval-to-az-tagrisso
arnu gutierrez
28/3/2017
20:49
....drugmaker AstraZeneca slipped 14.5p to £49.60 after Tesaro won US approval for ovarian cancer drug Zejula, a rival of its Lynparza drug. HTTP://www.telegraph.co.uk/business/2017/03/28/ftse-100-recovers-amid-hopes-trumps-healthcare-defeat-will-pave/
philanderer
23/3/2017
15:52
I don`t think this is a typo ;-) 23rd march Soc Gen 'buy' tp 7600p
philanderer
22/3/2017
22:59
'Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017' HTTP://marketrealist.com/2017/03/japan-may-prove-strong-growth-driver-astrazeneca-2017/
philanderer
20/3/2017
09:34
20th mar Berenberg buy tp 5670p up from 5450p 20th mar Deutsche buy tp 5500p reiterates
philanderer
17/3/2017
20:21
Circassia's shares soar as AstraZeneca takes $50m stake in business HTTP://www.telegraph.co.uk/business/2017/03/17/circassias-shares-soar-astrazeneca-takes-50m-stake-business/
philanderer
17/3/2017
09:26
FDA deals another blow to AstraZeneca’s ZS-9 blood drug 08:18 17 Mar 2017 ZS-9 is a treatment for hyperkalaemia – a condition where potassium levels in the blood are too high AstraZeneca PLC (LON:AZN) has suffered another setback with its ZS-9 hyperkalaemia treatment, which has been rejected for a second time by the US Food and Drug Administration. The drug maker told investors on Friday it has received a complete response letter - a formal rejection of approval for a new drug application – from the FDA. The pharma group said the CRL doesn’t require it to generate any new clinical which would’ve been time consuming, instead it seems that a few “matters”; need ironing out. Resolving such issues isn’t necessarily a formality though given that this was the position the company was in when its first application was knocked back last May. The rejections cast a shadow over AstraZeneca’s US$2.7bn acquisition of ZS Pharma back in 2015, which it primarily bought to gain access to the hyperkalaemia drug. Still, Astra has high hopes for ZS-9 – which it reckons can generate peak sales in excess of US$1bn a year – and will come back again with a revised application. proactiveinvestors.co.uk
philanderer
15/3/2017
13:19
Good health drives drug stocks rise HTTP://www.standard.co.uk/business/good-health-drives-drug-stocks-rise-a3490501.html
philanderer
15/3/2017
09:00
Am I reading the RNS's correctly and yet up a penny-halfpenny?
f1araway
09/3/2017
10:09
9th march Jefferies buy tp 5350p up from 5250p
philanderer
08/3/2017
08:46
Initiating coverage today... 8th march Barclays overweight tp 6000p
philanderer
07/3/2017
17:42
Trump`s at it again.. Donald Trump has ensured he remains the number one driver of volatility within the markets, with the President’s latest tweet dragging pharmaceutical firms lower today. "Trump’s promise to control drugs prices highlights that the optimism felt in response to Hilary Clinton’s election loss was clearly misplaced, proving that the topic remains one rare bipartisan area of agreement." HTTP://www.telegraph.co.uk/business/2017/03/07/pound-drops-seven-week-low-european-shares-slip-german-factory/
philanderer
Chat Pages: 412  411  410  409  408  407  406  405  404  403  402  401  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20170426 15:38:38